Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
mercaptopurine hypoxanthine-guanine phosphoribosyltransferase small molecule NA drugbank , DGIDB Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Severe Acute Respiratory Syndrome[MeSHID:D045169]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Middle East Respiratory Syndrome[MeSHID:D018352]		 2.65 approved inhibitor
mercaptopurine hypoxanthine-guanine phosphoribosyltransferase small molecule NA drugbank , DGIDB Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Crohn Disease[MeSHID:D003424]		 2.65 approved inhibitor
mercaptopurine inosine-5'-monophosphate dehydrogenase small molecule NA drugbank , DGIDB Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Crohn Disease[MeSHID:D003424]		 0.53 approved inhibitor
mercaptopurine inosine-5'-monophosphate dehydrogenase 1 NA Successful target TTD , DGIDB Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Severe Acute Respiratory Syndrome[MeSHID:D045169]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Middle East Respiratory Syndrome[MeSHID:D018352]		 0.53 approved unknown
mercaptopurine inosine-5'-monophosphate dehydrogenase small molecule NA drugbank , DGIDB Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Severe Acute Respiratory Syndrome[MeSHID:D045169]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Middle East Respiratory Syndrome[MeSHID:D018352]		 0.53 approved inhibitor
mercaptopurine inosine-5'-monophosphate dehydrogenase 1 NA Successful target TTD , DGIDB Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Crohn Disease[MeSHID:D003424]		 0.53 approved unknown
mercaptopurine inosine-5'-monophosphate dehydrogenase small molecule NA drugbank Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Severe Acute Respiratory Syndrome[MeSHID:D045169]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Middle East Respiratory Syndrome[MeSHID:D018352]		 NA approved inhibitor
mercaptopurine inosine-5'-monophosphate dehydrogenase small molecule NA drugbank Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Crohn Disease[MeSHID:D003424]		 NA approved inhibitor
mercaptopurine amidophosphoribosyltransferase small molecule Successful target TTD , drugbank , DGIDB Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Crohn Disease[MeSHID:D003424]		 1.33 approved inhibitor
mercaptopurine amidophosphoribosyltransferase small molecule Successful target TTD , drugbank , DGIDB Maintenance[MeSHID:D008283]
Lymphoid leukemia[MeSHID:D007945]
Severe Acute Respiratory Syndrome[MeSHID:D045169]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]
Middle East Respiratory Syndrome[MeSHID:D018352]		 1.33 approved inhibitor
click here to return to the previous page